Sanitizers Drive 2020 US OTC Drug Recalls To Double 2019 Total
Executive Summary
Sedgwick reported US OTC drug recalls in 2020 doubled to 61 driven by methanol contamination and GMP deviations in hand sanitizers. Once FDA resumes full inspection schedule, enforcement will be “more frequent, penalties will be harsher and cross-agency collaboration” will be welcome.
You may also be interested in...
Preparing For The Return Of US FDA Inspections
Compared to FY2019, FDA data show agency inspections of OTC and Rx drug manufacturing facilities in FY2020 fell 60%. As pandemic continues in FY2021, inspection rate will remain depressed, and it remains unclear how the agency will reduce the backlog without resorting to remotely conducted inspections.
US Seizes More Contaminated OTC Sanitizers From Mexico, Plus Subpotent Product From China
FDA also finding subpotent sanitizers made in China, according to warning letters submitted between 26 January and 5 February. Six recently warned firms began providing OTC sanitizers for distribution in the US after FDA in March temporarily loosened manufacturing standards.
After Finding Nitrosamine In Ranitidine, US Firm Suggests Link To Higher Cancer Diagnosis Rates
JAMA study found under simulated gastric conditions a standard tablet of ranitidine yielded NDMA to three orders of magnitude beyond established exposure limits. Rapid formation of NDMA appears to continue for extended periods in gastric conditions, say researchers from Memorial Sloan Kettering and Valisure.